Expanding Field of Dermatological Side Effects of Pharmaceuticals
DOI:
https://doi.org/10.2340/actadv.v104.42086Keywords:
side effects, pharmaceuticalsAbstract
Abstract is missing (Editorial)
Downloads
References
Del Pozzo-Magaña BR, Liy-Wong C. Drugs and the skin: a concise review of cutaneous adverse drug reactions. Br J Clin Pharmacol 2024; 90: 1838–1855.
https://doi.org/10.1111/bcp.15490 DOI: https://doi.org/10.1111/bcp.15490
Zalewska-Janowska A, Spiewak R, Kowalski ML. Cutaneous manifestation of drug allergy and hypersensitivity. Immunol Allergy Clin North Am 2017; 37: 165–181.
https://doi.org/10.1016/j.iac.2016.08.006 DOI: https://doi.org/10.1016/j.iac.2016.08.006
Scott LJ. Teriflunomide: a review in relapsing-remitting multiple sclerosis. Drugs 2019; 79: 875–886.
https://doi.org/10.1007/s40265-019-01135-8 DOI: https://doi.org/10.1007/s40265-019-01135-8
Goëb V, Berthelot JM, Joly P, Mejjad O, de Quatrebarbes J, Reynaud-Hautin C, et al. Leflunomide-induced subacute cutaneous lupus erythematosus. Rheumatology (Oxford) 2005; 44: 823–824.
https://doi.org/10.1093/rheumatology/keh586 DOI: https://doi.org/10.1093/rheumatology/keh586
Xu K, Zhang M, Yang S, Yu G, Zheng P, Qin X, et al. Subacute cutaneous lupus erythematosus as a rare complication of disease-modifying therapy administration in multiple sclerosis: case report. BMC Neurol 2023; 23: 168.
https://doi.org/10.1186/s12883-023-03146-1 DOI: https://doi.org/10.1186/s12883-023-03146-1
Negrotto L, Correale J. Palmar pustular psoriasis associated with teriflunomide treatment. Mult Scler Relat Disord 2019; 27: 400–402.
https://doi.org/10.1016/j.msard.2018.11.020 DOI: https://doi.org/10.1016/j.msard.2018.11.020
Agharbi FZ, Aasfara J, Oqbani K, Slamti K, Chiheb S. Lichenoid drug eruption induced by teriflunomide. Ann Indian Acad Neurol 2023; 26: 275–277.
https://doi.org/10.4103/aian.aian_27_23 DOI: https://doi.org/10.4103/aian.aian_27_23
Devarbhavi H, Ghabril M, Barnhart H, Patil M, Raj S, Gu J, et al. Leflunomide-induced liver injury: differences in characteristics and outcomes in Indian and US registries. Liver Int 2022; 42: 1323–1329.
https://doi.org/10.1111/liv.15189 DOI: https://doi.org/10.1111/liv.15189
Published
How to Cite
License
Copyright (c) 2024 Maria Palmetun-Ekbäck, Magnus Lindberg
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
